NKF honors researcher with Garabed Eknoyan Award
Click Here to Manage Email Alerts
Key takeaways:
- Cynthia Delgado, MD, received the Garabed Eknoyan Award.
- Delgado is a professor at the San Francisco Veterans Affairs Healthcare System and the University of California.
Cynthia Delgado, MD, received the Garabed Eknoyan Award for her guidance in removing race as a factor for diagnosing chronic kidney disease at the National Kidney Foundation Spring Clinical Meetings.
“Dr. Delgado’s work over the last 2 years as co-chair of the NKF-[American Society of Nephrology] ASN Task Force was truly groundbreaking and will be remembered in history as a turning point in kidney care. She is a recognized international expert on functional status, frailty, body composition and quality of life among individuals living with chronic kidney disease and that brought a unique perspective to the team and its work. The impact of the NKF-ASN Task Force recommendations is felt beyond our specialty as we strive towards equity in health care,” Sylvia E. Rosas, MD, MSCE, president of NKF, said in the release.
Delgado is a professor of medicine at the San Francisco Veterans Affairs Healthcare System and the University of California, the associate chief of nephrology for clinical operations and the director of the dialysis program for the San Francisco Veterans Affairs Healthcare System, as well as the chair of the ASN Diversity, Equity and Inclusion Committee.
“I am truly touched and honored to be this year's recipient of the Garabed Eknoyan Award,” Delgado said in the release. “Dr. Eknoyan was a true role model as a leader and humanitarian in support of patients living with kidney disease. My passion to work and serve the kidney health community comes from both family and professional experience. The burden of living with kidney disease overwhelms many aspects of patients' lives. I am focused on addressing the burden of kidney disease and improving life quality such that patients feel like individuals who happen to be living with kidney disease rather than being a kidney disease patient.”